Therapeutic Targets of Bufalin on Renal Carcinoma and Mechanisms: Experimental Validation of Network Pharmacology Analysis

The possible targets underlying the activity of bufalin on renal cell carcinoma (RCC) were investigated using network pharmacology and experimental approaches. PharmMapper and other databases were explored for predicting the bufalin targets and RCC-related targets. Finally, the enriched pathways and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Pan, Yi-Ming, Wang, Lu-Yao, Zhao, Wan-Zhu, Yang, Shao-Cheng, Sun, Xue-Fang, Guan, Xin, Yan, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816594/
https://www.ncbi.nlm.nih.gov/pubmed/35126601
http://dx.doi.org/10.1155/2022/5469795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816594/
https://www.ncbi.nlm.nih.gov/pubmed/35126601
http://dx.doi.org/10.1155/2022/5469795

Ejemplares similares